FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 131 filers reported holding FLEXION THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,964,000 | +76.6% | 485,975 | +138.3% | 0.00% | – |
| Q2 2021 | $1,678,000 | -11.4% | 203,900 | -3.6% | 0.00% | – |
| Q1 2021 | $1,894,000 | -59.8% | 211,616 | -48.2% | 0.00% | -100.0% |
| Q4 2020 | $4,711,000 | +2.6% | 408,294 | -7.4% | 0.00% | +100.0% |
| Q3 2020 | $4,592,000 | -49.5% | 441,160 | -36.1% | 0.00% | -66.7% |
| Q2 2020 | $9,086,000 | +269.7% | 690,918 | +121.1% | 0.00% | +200.0% |
| Q1 2020 | $2,458,000 | -63.3% | 312,444 | -3.4% | 0.00% | -50.0% |
| Q4 2019 | $6,695,000 | +48.2% | 323,429 | -1.9% | 0.00% | 0.0% |
| Q3 2019 | $4,517,000 | +130.6% | 329,540 | +106.9% | 0.00% | +100.0% |
| Q2 2019 | $1,959,000 | -53.5% | 159,258 | -52.9% | 0.00% | -50.0% |
| Q1 2019 | $4,216,000 | +15.3% | 337,810 | +4.6% | 0.00% | 0.0% |
| Q4 2018 | $3,658,000 | +41.2% | 323,105 | +133.4% | 0.00% | +100.0% |
| Q3 2018 | $2,590,000 | +192.0% | 138,419 | +303.6% | 0.00% | – |
| Q2 2018 | $887,000 | -77.3% | 34,300 | -80.3% | 0.00% | -100.0% |
| Q1 2018 | $3,899,000 | +660.0% | 173,962 | +748.6% | 0.00% | – |
| Q4 2017 | $513,000 | -80.0% | 20,500 | -80.6% | 0.00% | -100.0% |
| Q3 2017 | $2,560,000 | +80.7% | 105,882 | +51.0% | 0.00% | +100.0% |
| Q2 2017 | $1,417,000 | -50.3% | 70,100 | -33.9% | 0.00% | -66.7% |
| Q1 2017 | $2,852,000 | +120.2% | 106,000 | +55.6% | 0.00% | +200.0% |
| Q4 2016 | $1,295,000 | +42.9% | 68,123 | +12.6% | 0.00% | 0.0% |
| Q2 2016 | $906,000 | +815.2% | 60,522 | +1083.0% | 0.00% | – |
| Q4 2015 | $99,000 | -80.7% | 5,116 | -78.2% | 0.00% | – |
| Q2 2015 | $514,000 | – | 23,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|